EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Acne scars topical treatment: Endolift® direct optical energy using 1470-nm wavelength Eufoton® LASEmaR® 1500

I. B Sitohang, Dinko Kaliterna, M Kamalska, A Abdelmaksoud, N. E Tsoureli

Journal of Applied Cosmetology · 2023

DOI: 10.56609/jac.v41i1.71 ↗
AbstractBibliografische Angaben

Abstract

The present work was designed to evaluate the efficiency of the procedure Endolift® studied to reduce skin depression and scars. Thirty patients with acne scars, mostly deep rolling, of both sex ranging from 19 to 32 year-of-age, were treated; 30% of them presented active acne. The Endolift® laser treatment is based on wavelength 1470-nm of the device Eufoton® LASEmaR® 1500 and LIGHTSCAN™ - a fractional, non-ablative laser treatment. Only one session of 300-mm diameter laser fibre inserted under the skin was performed; 70% of enrolled patients were without anaesthesia, and 30% were treated with air-cooling systems or block anaesthesia. Sixty-five% of the patients reported immediate smoothing of the scars with only one application; for the 35%, we used 2 to 3 treatments based on LIGHTSCAN™ to keep acne under control. Twenty patients with rolling scars needed only one session of treatment to reach optimal results; 10 patients with other types of acne scars reported moderate to medium improvement and needed a second treatment. Although day-by-day improvement was visible, the final result was obtained after 12 months. The treatment had permanent results, and there were no downtimes or side effects. Laser sub-incision is a game changer for acne scar treatments, especially deep rolling scars.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →